🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of the suggested study is to assess the added value of 68Ga-FAPI-04...
Status
Unknown
Location
Tel Aviv Sourasky medial center
Start Date
2020-06-11
Trial ID
NCT04441606
Treatments Being Tested
In this study the investigators aim to examine the role that fibrosis plays...
Status
Completed
Location
University of Edinburgh
Start Date
2022-11-10
Trial ID
NCT05756608
Treatments Being Tested
As a new dual receptor (SSTR2 and FAP) targeting PET radiotracer, 68Ga-FAPI...
Status
Recruiting
Location
The First Affiliated Hospital of Xiamen University
Start Date
2023-04-09
Trial ID
NCT05873777
Treatments Being Tested
This study aims to evaluate the diagnostic efficacy and prognostic value of...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2026-02-01
Trial ID
NCT07370805
Treatments Being Tested
As a novel radiotracer targeting fibroblast activation protein (FAP), 68Ga-...
Status
Unknown
Location
The First Affiliated Hospital of Fujian Medical University
Start Date
2024-04-01
Trial ID
NCT06455761
Treatments Being Tested
The clinical feasibility of 18F-FAPI-RGD PET/CT will be evaluated in 100 pa...
Status
Unknown
Location
Departments of Nuclear Medicine, Sichuan Provincial People's Hospital
Start Date
2023-04-10
Trial ID
NCT06094530
To explore the potential utility of 18F-FAPI-04 PET/CT for pathologic respo...
Status
Completed
Location
First Affiliated Hospital, Medical College of Zhejiang University
Start Date
2021-08-04
Trial ID
NCT06277206
Treatments Being Tested
Fibroblast-activation protein (FAP) is a type Ⅱ transmembrane serine protea...
Status
Recruiting
Location
Zhongnan Hospital of Wuhan University
Start Date
2021-02-23
Trial ID
NCT05034146
The goal of this clinical trial is to investigate whether new imaging techn...
Status
Recruiting
Location
University Hospital Zurich
Start Date
2025-10-20
Trial ID
NCT07112066
Treatments Being Tested
Evaluating fluoro-18-fibroblast activation protein inhibitor-04 positron em...
Status
Completed
Location
The Second Hospital of Lanzhou University
Start Date
2022-04-01
Trial ID
NCT06206642
Treatments Being Tested